Cytek Biosciences CTKB
NASDAQ CTKB
$5.91 +0.14 (+2.52%)
As of: Sep 30, 2026 · 3:49 PM EDT

Cytek Biosciences (CTKB) EV to EBITDA (2021 - 2022)

Updated

Cytek Biosciences' EV to EBITDA was 1577.73 in Q4 2022, compared with 85.37 a year earlier and up 77.1% from the prior quarter.

Analysis

Cytek Biosciences (CTKB) EV to EBITDA (2021 - 2022) Analysis & Trends

From Q3 2021 onward, Cytek Biosciences has reported EV to EBITDA for 6 quarters.

  • In earlier years, EV to EBITDA was 85.37 in FY2021.
  • Per Business Quant data, CTKB's EV to EBITDA in the three quarters before Q4 2022 was 890.76 (Q3 2022), 312.77 (Q2 2022) and 143.91 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Cytek Biosciences 748.70 Mn 424.97 Mn 28.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1,577.73
Sep 30, 2022 890.76
Jun 30, 2022 312.77
Mar 31, 2022 143.91
Dec 31, 2021 85.37
Sep 30, 2021 118.21
API Access

Cytek Biosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CTKB&period=max&api_key=YOUR_API_KEY